Please use this identifier to cite or link to this item:
Title: Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts
Authors: Moreira, Ana C. 
Branco, Ana F. 
Sampaio, Susana F. 
Cunha-Oliveira, Teresa 
Martins, Tatiana R. 
Holy, Jon 
Oliveira, Paulo J. 
Sardão, Vilma A. 
Keywords: Active Transport, Cell Nucleus; Amino Acid Chloromethyl Ketones; Animals; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Inducing Factor; Blotting, Western; Caspase Inhibitors; Caspases; Cell Line; Cell Nucleus; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Microscopy, Confocal; Mitochondria; Models, Biological; Myocytes, Cardiac; RNA Interference; Rats; Time Factors
Issue Date: Dec-2014
Serial title, monograph or event: Biochimica et biophysica acta
Volume: 1842
Issue: 12 Pt A
Abstract: The cardiotoxicity induced by the anti-cancer doxorubicin involves increased oxidative stress, disruption of calcium homeostasis and activation of cardiomyocyte death. Nevertheless, antioxidants and caspase inhibitors often show little efficacy in preventing cell death. We hypothesize that a caspase-independent cell death mechanism with the release of the apoptosis-inducing factor from mitochondria is involved in doxorubicin toxicity. To test the hypothesis, H9c2 cardiomyoblasts were used as model for cardiac cells. Our results demonstrate that z-VAD-fmk, a pan-caspase inhibitor, does not prevent doxorubicin toxicity in this cell line. Doxorubicin treatment results in AIF translocation to the nuclei, as confirmed by Western Blotting of cell fractions and confocal microscopy. Also, doxorubicin treatment of H9c2 cardiomyoblasts resulted in the appearance of 50kbp DNA fragments, a hallmark of apoptosis-inducing factor nuclear effects. Apoptosis-inducing factor knockdown using a small-interfering RNA approach in H9c2 cells resulted in a reduction of doxorubicin toxicity, including decreased p53 activation and poly-ADP-ribose-polymerase cleavage. Among the proteases that could be responsible for apoptosis-inducing factor cleavage, doxorubicin decreased calpain activity but increased cathepsin B activation, with inhibition of the latter partly decreasing doxorubicin toxicity. Altogether, the results support that apoptosis-inducing factor release is involved in doxorubicin-induced H9c2 cell death, which explains the limited ability of caspase inhibitors to prevent toxicity.
DOI: 10.1016/j.bbadis.2014.09.015
Rights: openAccess
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
24_Moreira BBA MBD 2014.pdf1.6 MBAdobe PDFView/Open
Show full item record


checked on Feb 19, 2024

Citations 5

checked on May 2, 2023

Page view(s) 20

checked on Feb 20, 2024

Download(s) 50

checked on Feb 20, 2024

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.